CardioVascular Center Frankfurt
Frankfurt am Main, Hesse, 60389, Germany
NCT Number: NCT01834118
The purpose of this study is to determine the effect of repeated renal denervation in non-responding patients with severe hypertension. Therefore ultrasound technique will be used.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Frankfurt am Main, Hesse, 60389, Germany
Renal Denervation is a CE-certified opportunity for treating patients with therapy-refractory hypertension. In some patients it doesn't show a significant lowering of the blood pressure, so a repeated renal denervation is an option.
In this study repeated renal denervation will be performed with the Recor Paradise Ultrasound Catheter.
For the study no specific procedures are required which would exceed the standard renal denervation procedure with the CE-certified Recor Paradise Ultrasound Catheter System.
There are no additional risks for the patient in consequence of participating in the study or the follow up procedures.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Sympathetic nerve ablation via transcatheter renal denervation
Other names: Renal sympathetic nerve ablation
Time frame: up to1 year
Cardiovascular Center Frankfurt
Other
Reintervention After Previous Renal Denervation in Non-responding Patients With Severe Hypertension
Acronym: RETREAT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05395403
Cardiovascular Diseases, Hypertension
Birmingham, Alabama, United States
View Trial DetailsNCT02667912
Cardiovascular Diseases, Hypertension
Tomsk, Russia
View Trial DetailsNCT01520506
Cardiovascular Diseases, Chronic Disease
Antwerp, Belgium
View Trial DetailsNCT01570777
Cardiovascular Diseases, Essential Hypertension
Paris, France
View Trial Details